CLGN
CollPlant Biotechnologies Ltd. NASDAQ Listed Jan 31, 2018$0.34
-0.03%
vs $0.34
Mkt Cap $4.2M
52w Low $0.27
2.3% of range
52w High $3.23
50d MA $0.38
200d MA $1.23
P/E (TTM)
—
EV/EBITDA
—
P/B
0.7x
Debt/Equity
0.5x
ROE
-188.9%
P/FCF
-0.4x
RSI (14)
52.70
ATR (14)
$0.05
Beta
0.94
50d MA
$0.38
200d MA
$1.23
Avg Volume
71.2K
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Weizmann Science Park · Rehovot, L3 7670104 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | BMO | -0.24 | -0.23 | +3.1% | 0.41 | +3.7% | -0.7% | -0.2% | -0.2% | -0.1% | -1.3% | — |
| Mar 26, 2026 | BMO | -0.30 | -0.67 | -125.1% | 0.66 | +7.6% | -5.5% | -5.4% | -9.2% | -0.4% | -0.9% | — |
| Nov 26, 2025 | BMO | 0.38 | -0.27 | -171.1% | 2.23 | +0.0% | -1.8% | -5.5% | +3.4% | -3.3% | +1.4% | — |
| Aug 20, 2025 | BMO | -0.10 | -0.28 | -180.0% | 1.97 | -1.5% | +21.8% | +5.0% | +4.4% | +3.0% | +7.4% | — |
| May 28, 2025 | BMO | -0.37 | -0.13 | +64.9% | 3.40 | -6.5% | +33.5% | -30.0% | -28.3% | +11.4% | -13.4% | — |
| Mar 26, 2025 | BMO | -0.42 | -0.34 | +19.0% | 2.71 | -4.1% | -2.2% | -3.8% | +1.2% | -0.4% | +0.4% | — |
| Nov 27, 2024 | BMO | -0.28 | -0.38 | -35.7% | 4.25 | +0.0% | +5.4% | -2.2% | -5.7% | -1.7% | -3.4% | — |
| Aug 20, 2024 | BMO | -0.35 | -0.37 | -5.7% | 4.85 | -3.5% | +0.2% | +6.8% | -2.5% | +0.8% | +0.2% | — |
| Apr 4, 2024 | BMO | -0.35 | -0.42 | -20.0% | 5.26 | +0.2% | -3.0% | +0.2% | +2.3% | +0.2% | -0.2% | — |
| Jan 25, 2024 | BMO | -0.07 | -0.24 | -242.9% | 5.17 | +2.1% | -3.3% | +5.0% | +0.0% | +4.4% | +0.2% | — |
| Nov 29, 2023 | BMO | -0.13 | -0.38 | -192.3% | 5.35 | -0.9% | +2.4% | -2.4% | -2.2% | +5.2% | +0.0% | — |
| Aug 24, 2023 | BMO | 0.01 | 0.49 | +3166.7% | 6.69 | +2.5% | +5.2% | -1.7% | -6.1% | -0.2% | +4.2% | — |
| May 24, 2023 | BMO | -0.29 | -0.33 | -13.8% | 7.61 | -0.8% | -6.6% | +2.0% | +1.9% | +5.3% | -2.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6 | D. Boral Capital | Downgrade | Buy → Hold | — | $0.75 | $0.83 | +10.7% | +6.7% | -19.5% | +9.1% | -5.1% | +1.9% |
| Nov 28 | D. Boral Capital | Maintains | Buy → Buy | — | $2.23 | $2.23 | +0.0% | -1.8% | -5.5% | +3.4% | -3.3% | +1.4% |
| Oct 20 | D. Boral Capital | Maintains | Buy → Buy | — | $2.32 | $2.40 | +3.4% | +7.3% | -4.8% | -4.6% | +0.9% | +0.0% |
| Sep 16 | D. Boral Capital | Maintains | Buy → Buy | — | $2.63 | $2.60 | -1.1% | -1.9% | +1.6% | +0.8% | -4.5% | -1.2% |
| Aug 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.97 | $1.94 | -1.5% | +21.8% | +5.0% | +4.4% | +3.0% | +7.4% |
| Aug 20 | D. Boral Capital | Maintains | Buy → Buy | — | $2.47 | $2.27 | -8.1% | -20.2% | +21.8% | +5.0% | +4.4% | +3.0% |
| May 30 | D. Boral Capital | Maintains | Buy → Buy | — | $4.54 | $3.60 | -20.7% | -30.0% | -28.3% | +11.4% | -13.4% | -6.8% |
| May 28 | D. Boral Capital | Maintains | Buy → Buy | — | $1.93 | $2.00 | +3.6% | +76.2% | +33.5% | -30.0% | -28.3% | +11.4% |
| Mar 27 | D. Boral Capital | Maintains | Buy → Buy | — | $2.71 | $2.60 | -4.1% | -2.2% | -3.8% | +1.2% | -0.4% | +0.4% |
| Feb 12 | D. Boral Capital | Maintains | Buy → Buy | — | $3.55 | $3.85 | +8.5% | +4.2% | +1.9% | -4.5% | +0.0% | -0.3% |
| Feb 4 | D. Boral Capital | Maintains | Buy → Buy | — | $3.73 | $3.71 | -0.5% | +1.3% | -0.8% | -0.8% | -1.6% | -3.0% |
| Nov 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.25 | $4.25 | +0.0% | +5.4% | -2.2% | -5.7% | -1.7% | -3.4% |
| Nov 27 | D. Boral Capital | Maintains | Buy → Buy | — | $4.26 | $3.55 | -16.7% | -0.2% | +5.4% | -2.2% | -5.7% | -1.7% |
| Aug 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.85 | $4.68 | -3.5% | +0.2% | +6.8% | -2.5% | +0.8% | +0.2% |
| Aug 20 | EF Hutton | Maintains | Buy → Buy | — | $4.91 | $4.85 | -1.2% | -1.2% | +0.2% | +6.8% | -2.5% | +0.8% |
| May 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.67 | $5.49 | -3.2% | -3.0% | +2.0% | -2.0% | -1.8% | -2.8% |
| Apr 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.26 | $5.27 | +0.2% | -3.0% | +0.2% | +2.3% | +0.2% | -0.2% |
| Nov 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.35 | $5.30 | -0.9% | +2.4% | -2.4% | -2.2% | +5.2% | +0.0% |
| Aug 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.69 | $6.86 | +2.5% | +5.2% | -1.7% | -6.1% | -0.2% | +4.2% |
| Mar 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.74 | $6.60 | -2.1% | -0.0% | +4.2% | -0.1% | +5.3% | -0.8% |
| Feb 17 | Alliance Global Partners | Maintains | Buy → Buy | — | $11.80 | $11.92 | +1.0% | +0.9% | -3.0% | -2.6% | +3.0% | -3.3% |
| Feb 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.58 | $22.54 | +4.4% | -8.2% | +15.7% | +5.8% | -32.2% | +0.9% |
| Nov 25 | H.C. Wainwright | Maintains | Buy → Buy | — | $7.78 | $7.71 | -0.9% | +2.6% | -1.6% | +1.0% | +29.0% | -8.8% |
| Nov 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.78 | $7.71 | -0.9% | +2.6% | -1.6% | +1.0% | +29.0% | -8.8% |
| May 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.07 | $10.09 | +0.2% | -2.5% | +4.9% | -1.9% | +1.5% | +1.0% |
| Apr 3 | H.C. Wainwright | Maintains | Buy → Buy | — | $8.38 | $8.86 | +5.7% | -1.0% | +4.3% | +4.5% | +7.6% | +3.2% |
| Dec 18 | H.C. Wainwright | Maintains | Buy → Buy | — | $4.35 | $4.98 | +14.5% | +8.9% | -3.0% | -3.3% | +0.9% | -3.1% |
No insider trades available.
No recent filings available.
Valuation
Market Cap
$4.2M
Enterprise Value
-$1.8M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.04x
P/B
0.68x
P/S
10.67x
P/FCF
-0.44x
EV/EBITDA
—
Shares Out
12.2M
Financials (TTM)
Revenue
$389K
Net Income
-$13.1M
EBITDA
-$12.0M
Free Cash Flow
-$9.4M
Op Cash Flow
-$9.4M
EPS Basic
$-0.94
EPS Diluted
$-1.03
EPS Forward
$-0.59
Gross Margin
-319.3%
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$10.8M
Total Liab.
$4.7M
Total Equity
$6.1M
Cash
$6.0M
LT Debt
$0
Book Value/Sh
$0.50
Debt/Equity
0.47x
Current Ratio
2.53
Quick Ratio
2.31
Returns & Growth
ROE
-188.9%
ROA
-106.5%
ROIC
-128.6%
Rev Growth YoY
+360.4%
EPS Growth YoY
+35.2%
Price Returns
2W
+0.9%
1M
-14.9%
3M
-22.9%
6M
-77.0%
12M
-75.3%
Technicals
52W High
$3.23
52W Low
$0.27
50d MA
$0.38
200d MA
$1.23
RSI (14)
52.70
ATR (14)
$0.05
Beta
0.94
Avg Volume
71K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$12.50
High
$14.00
Low
$11.00
Median
$12.50
Data updated apr 25, 2026 1:39am
· Source: financialmodelingprep.com